Lv1
30 积分 2020-12-20 加入
2023 FIGO staging system for endometrial cancer: The evolution of the revolution
19小时前
待确认
Improved prognostic stratification with 2023 FIGO staging in endometrial cancer reflecting poor prognosis of aggressive histological types and p53 abnormality
19小时前
求助中
Molecular testing for endometrial cancer: An SGO clinical practice statement
22天前
已完结
Endometrial cancer
28天前
已完结
Human epidermal growth factor 2 (HER2) amplification in uterine serous carcinoma: an analysis of prognosis and immune microenvironment
28天前
已完结
Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA
1个月前
已完结
Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma
1个月前
已关闭
Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA
1个月前
已关闭
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
1个月前
已完结
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC
1个月前
已完结
皖公网安备34019202002308
